DARETherapeutics - Developing a Next Generation Treatment for Wet AMD and DME
A novel target and antibody for stand-alone or combination therapeutics against conditions involving neovascularization
Published: 25th June 2019

Patents
- Intellectual property rights are held by University of Southern Denmark (WO2014114298 and EP17199552.5).
IP Status
- Patent application submitted
Seeking
- Seeking investment
- Development partner
- Commercial partner